Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK31858 in non-cystic fibrosis bronchiectasis
NCT05601778Phase 2Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Dec 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK31858 in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Dec 2022; status: completed.
02
Drugs
HSK31858
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT05601778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05601778.